What is the maximum dose of midazolam (Benzodiazepine) for a 13-year-old pediatric patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Maximum Dose of Midazolam in a 13-Year-Old Patient

For a 13-year-old patient, the maximum dose of midazolam depends on the route of administration and indication, but generally should not exceed 10 mg total regardless of calculated weight-based dosing.

Route-Specific Maximum Doses

Intravenous (IV) Administration

  • Initial dose: 0.025-0.05 mg/kg titrated slowly over 2-3 minutes 1
  • Maximum total dose: Up to 0.4 mg/kg may be needed but should not exceed 10 mg total 1
  • For sedation/anxiolysis: 13-year-olds should be dosed similar to adults, though some patients in this age range may require higher than recommended adult doses 1

Oral Administration

  • Dose range: 0.25-0.5 mg/kg 2, 3
  • Maximum total dose: Should not exceed 20 mg regardless of weight 2
  • Caution: Doses above 0.5 mg/kg increase risk of adverse effects without significantly improving efficacy 3

Intramuscular (IM) Administration

  • Usual dose: 0.1-0.15 mg/kg 1
  • Maximum dose: Up to 0.5 mg/kg for more anxious patients 1
  • Total dose: Should not exceed 10 mg total 1

Continuous IV Infusion

  • Initial rate: 0.06-0.12 mg/kg/hr (1-2 mcg/kg/min) 1
  • Titration: Can be increased or decreased by 25% of initial rate as required 1

Indication-Specific Considerations

For Procedural Sedation

  • Sedation/anxiolysis: 0.05-0.1 mg/kg IV initially, titrated to effect 4
  • For seizures: 0.2 mg/kg IM (maximum: 6 mg per dose); may repeat every 10-15 min 4
  • For refractory status epilepticus: Loading dose 0.15-0.20 mg/kg IV, followed by continuous infusion 4

For Agitation Management

  • Adolescent dose: 0.1 mg/kg IV/IM/PO 4

Safety Considerations

  1. Respiratory depression risk: Higher with:

    • Combination with opioids (reduce both doses when used together) 1
    • Rapid administration 1
    • Higher doses 3
  2. Monitoring requirements:

    • Continuous pulse oximetry 4
    • Capnography recommended for moderate/deep sedation 5
    • Observation for paradoxical reactions (especially in younger children) 5
  3. Reversal agent:

    • Flumazenil should be readily available for emergency reversal 4
    • Note that flumazenil will also reverse anticonvulsant effects 4

Important Cautions

  • Prolonged sedation and hypoventilation risk increases with higher doses 1
  • Midazolam doses should be reduced in patients premedicated with opioids 1
  • Desaturation episodes (SpO₂ <90%) occur in approximately 8.4% of cases 6
  • Half-life in children over 12 months is 0.8-1.8 hours 7
  • Drug elimination may be delayed in patients receiving erythromycin or with liver dysfunction 1

Bottom Line

When administering midazolam to a 13-year-old patient, start with the lowest effective dose and titrate carefully while monitoring vital signs. The maximum total dose should not exceed 10 mg IV/IM or 20 mg PO regardless of the patient's weight, with careful consideration of potential respiratory depression, especially when combined with other sedatives or opioids.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Sedation for Medical Procedures

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Use of midazolam and ketamine as sedation for children undergoing minor operative procedures.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2005

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.